234 related articles for article (PubMed ID: 24265728)
21. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
22. Roles of AMP-activated protein kinase in Alzheimer's disease.
Cai Z; Yan LJ; Li K; Quazi SH; Zhao B
Neuromolecular Med; 2012 Mar; 14(1):1-14. PubMed ID: 22367557
[TBL] [Abstract][Full Text] [Related]
23. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
24. Identification of therapeutic targets for Alzheimer's disease via differentially expressed gene and weighted gene co-expression network analyses.
Jia Y; Nie K; Li J; Liang X; Zhang X
Mol Med Rep; 2016 Nov; 14(5):4844-4848. PubMed ID: 27748870
[TBL] [Abstract][Full Text] [Related]
25. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
26. Intrinsic-overlapping co-expression module detection with application to Alzheimer's Disease.
Manners HN; Roy S; Kalita JK
Comput Biol Chem; 2018 Dec; 77():373-389. PubMed ID: 30466046
[TBL] [Abstract][Full Text] [Related]
27. Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.
Gao S; Casey AE; Sargeant TJ; Mäkinen VP
Brain; 2018 Sep; 141(9):2711-2720. PubMed ID: 30124770
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease.
Silva AR; Grinberg LT; Farfel JM; Diniz BS; Lima LA; Silva PJ; Ferretti RE; Rocha RM; Filho WJ; Carraro DM; Brentani H
PLoS One; 2012; 7(11):e48751. PubMed ID: 23144955
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
30. An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
Elkahloun AG; Hafko R; Saavedra JM
Alzheimers Res Ther; 2016 Jan; 8():5. PubMed ID: 26822027
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer's disease.
Hu W; Lin X; Chen K
Mol Med Rep; 2015 Nov; 12(5):6679-87. PubMed ID: 26324066
[TBL] [Abstract][Full Text] [Related]
32. Co-expression Network Analysis Revealing the Potential Regulatory Roles of lncRNAs in Alzheimer's Disease.
Wu J; Chen L; Zheng C; Xu S; Gao Y; Wang J
Interdiscip Sci; 2019 Dec; 11(4):645-654. PubMed ID: 30715720
[TBL] [Abstract][Full Text] [Related]
33. Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients.
Liu ZP; Wang Y; Zhang XS; Xia W; Chen L
Mol Biosyst; 2011 May; 7(5):1441-52. PubMed ID: 21336338
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Shared Genetic Regulatory Networks for Alzheimer's Disease and Epilepsy.
Wang XD; Liu S; Lu H; Guan Y; Wu H; Ji Y
Biomed Res Int; 2021; 2021():6692974. PubMed ID: 34697589
[TBL] [Abstract][Full Text] [Related]
35. Hippocampal transcriptome profiling combined with protein-protein interaction analysis elucidates Alzheimer's disease pathways and genes.
van Rooij JGJ; Meeter LHH; Melhem S; Nijholt DAT; Wong TH; ; Rozemuller A; Uitterlinden AG; van Meurs JG; van Swieten JC
Neurobiol Aging; 2019 Feb; 74():225-233. PubMed ID: 30497016
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
37. Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
Liang J; LaFleur B; Hussainy S; Perry G
J Alzheimers Dis; 2024; 99(s2):S249-S263. PubMed ID: 37092222
[TBL] [Abstract][Full Text] [Related]
38. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis.
Han ZJ; Xue WW; Tao L; Zhu F
CNS Neurosci Ther; 2018 Dec; 24(12):1253-1263. PubMed ID: 30106219
[TBL] [Abstract][Full Text] [Related]
40. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
